Author: R.J. Hay
Edition: 1
Publisher: CRC Press
Binding: Hardcover
ISBN: 1842140477
Lamisil: The Evidence
This is an authoritative clinical text on the use of oral terbinafine (Lamisil) as first-line therapy for onychomycosis (fungal nail infections) and as a rational choice for fungal skin infections that require oral therapy. Medical books Lamisil. Author Doctor R.J. Hay, reviews the data on Lamisil, presenting much of it in the form of especially helpful tables. Individual chapters cover pharmacology and pharmacokinetics and the use of Lamisil tablets in onychomycosis, tinea capitis, dermatomycoses, subcutaneous and systemic mycoses and other infectious diseases Medical books Lamisil At Cream. Terbinafine Hydrochloride Cream 1%. Cures most athlete's foot. Relieves itching and burning. Full prescription strength. Lamisil
Download link for Lamisil AT AT Antifungal Cream
Terbinafine Hydrochloride Cream 1%. Cures most athlete's foot. Relieves itching and burning. Full prescription strength. Lamisil
The Lamisil Antifungal Cream is effectively medicated to treat most athlete s foot within a two-week period. It is enriched with the Terbinafine Hydrochloride-1% antifungal formula, which relieves itching, burning, cracking and scaling associated with athlete's foot. This athlete s foot antifungal cream stops fungal growth, thereby, curing the infection. It is advised to apply this Lamisil AT cream to the infected areas twice a day. The Lamisil Antifungal Cream cures most athlete's foot.
Terbinafine Hydrochloride Cream 1% - Antifungal Relieves Itching, Burning, Cracking and Scaling Clinically proven to cure most athlete s foot nbsp; | Full Prescription Strength
Relieves itching and burning. Full prescription strength. Net Wt 12g (.42 oz)..
Medical Book Lamisil
Author Doctor R.J. Hay, reviews the data on Lamisil, presenting much of it in the form of especially helpful tables. Individual chapters cover pharmacology and pharmacokinetics and the use of Lamisil tablets in onychomycosis, tinea capitis, dermatomycoses, subcutaneous and systemic mycoses and other infectious diseases. Dr. Hay also provides a chapter on the safety and tolerability of Lamisil tablets, including the postmarketing surveillance study and interactions with other drugs.
